Shusterman B, Mchedishvili G, Rosner M H
Division of Nephrology, University of Virginia Health System, Charlottesville, VA 22908, USA.
Transplant Proc. 2007 Jun;39(5):1496-500. doi: 10.1016/j.transproceed.2007.01.087.
Acute kidney injury occurs commonly among patients with advanced liver disease. These patients may undergo liver transplantation with subsequent improvement in hepatic function. However, the renal outcomes of these patients after liver transplantation has only occasionally been reported. Knowledge of these outcomes would be useful to identify patients who may benefit from combined liver-renal transplantation. We retrospectively analyzed 29 patients who subsequently went on to have a liver transplantation. Seventeen of cases could be ascribed to hepatorenal syndrome (HRS) and 12 cases to ATN. Four patients with non-HRS and 12 patients with HRS required hemodialysis prior to transplantation. The duration of kidney injury prior to transplantation was 7.75 +/- 7.53 weeks in the HRS group and 5.09 +/- 4.47 weeks in the ATN group (P = NS). Demographic variables between patients with HRS and ATN were similar with the exception of a higher prevalence of diabetes among the ATN group (P < .05). At 3 months post-liver transplantation, 66% of patients with non-HRS and 77% of those surviving patients with HRS showed serum creatinine values less than 1.5 mg/dL. No patients remained on chronic hemodialysis at 3 months post-liver transplantation. The outcome of kidney dysfunction and more specifically, HRS, among those patients surviving to liver transplantation was excellent with subsequent resolution in the majority of patients. Determination of prognostic factors for renal outcome will require multicenter prospective trials, which would be useful to determine which patients benefit from combined liver-renal transplantation.
急性肾损伤在晚期肝病患者中很常见。这些患者可能会接受肝移植,随后肝功能会有所改善。然而,这些患者肝移植后的肾脏转归仅偶尔有报道。了解这些转归对于识别可能从肝肾联合移植中获益的患者会很有帮助。我们回顾性分析了29例随后接受肝移植的患者。其中17例可归因于肝肾综合征(HRS),12例归因于急性肾小管坏死(ATN)。4例非HRS患者和12例HRS患者在移植前需要进行血液透析。移植前肾脏损伤的持续时间在HRS组为7.75±7.53周,在ATN组为 5.09±4.47周(P=无显著性差异)。HRS患者和ATN患者之间的人口统计学变量相似,只是ATN组糖尿病患病率较高(P<0.05)。肝移植后3个月,66%的非HRS患者和77%存活的HRS患者血清肌酐值低于1.5mg/dL。肝移植后3个月没有患者仍在接受慢性血液透析。在存活至肝移植的患者中,肾功能不全尤其是HRS的转归非常好,大多数患者随后病情得到缓解。确定肾脏转归的预后因素需要多中心前瞻性试验,这对于确定哪些患者能从肝肾联合移植中获益会很有帮助。